Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Bicalutamide Market Growth 2022-2028

  • LP 4832661
  • 109 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Bicalutamide will have significant change from previous year. According to our (LP Information) latest study, the global Bicalutamide market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bicalutamide market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Bicalutamide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bicalutamide market, reaching US$ million by the year 2028. As for the Europe Bicalutamide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Bicalutamide players cover AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, and Actavis Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Bicalutamide market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Tablets

Capsule

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Single Drug For Prostate Cancer

Combined Chemotherapy For Prostate Cancer

Combined Radiation Therapy Or Castration For Prostate Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AstraZeneca

CORDEN PHARMA GMBH

Zeneca GmbH

Actavis Pharma

Sivem Pharmaceuticals

Sorres Pharma

Fresenius Kabi

ANI Pharmaceuticals

Accel Pharma

Apotex Corporation

Shanghai Fudan Fuhua Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Zhejiang Haizheng Pharmaceutical

Shanxi Zhendong Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bicalutamide Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bicalutamide by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bicalutamide by Country/Region, 2017, 2022 & 2028

2.2 Bicalutamide Segment by Type

2.2.1 Tablets

2.2.2 Capsule

2.3 Bicalutamide Sales by Type

2.3.1 Global Bicalutamide Sales Market Share by Type (2017-2022)

2.3.2 Global Bicalutamide Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bicalutamide Sale Price by Type (2017-2022)

2.4 Bicalutamide Segment by Application

2.4.1 Single Drug For Prostate Cancer

2.4.2 Combined Chemotherapy For Prostate Cancer

2.4.3 Combined Radiation Therapy Or Castration For Prostate Cancer

2.5 Bicalutamide Sales by Application

2.5.1 Global Bicalutamide Sale Market Share by Application (2017-2022)

2.5.2 Global Bicalutamide Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bicalutamide Sale Price by Application (2017-2022)

3 Global Bicalutamide by Company

3.1 Global Bicalutamide Breakdown Data by Company

3.1.1 Global Bicalutamide Annual Sales by Company (2020-2022)

3.1.2 Global Bicalutamide Sales Market Share by Company (2020-2022)

3.2 Global Bicalutamide Annual Revenue by Company (2020-2022)

3.2.1 Global Bicalutamide Revenue by Company (2020-2022)

3.2.2 Global Bicalutamide Revenue Market Share by Company (2020-2022)

3.3 Global Bicalutamide Sale Price by Company

3.4 Key Manufacturers Bicalutamide Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bicalutamide Product Location Distribution

3.4.2 Players Bicalutamide Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bicalutamide by Geographic Region

4.1 World Historic Bicalutamide Market Size by Geographic Region (2017-2022)

4.1.1 Global Bicalutamide Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bicalutamide Annual Revenue by Geographic Region

4.2 World Historic Bicalutamide Market Size by Country/Region (2017-2022)

4.2.1 Global Bicalutamide Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bicalutamide Annual Revenue by Country/Region

4.3 Americas Bicalutamide Sales Growth

4.4 APAC Bicalutamide Sales Growth

4.5 Europe Bicalutamide Sales Growth

4.6 Middle East & Africa Bicalutamide Sales Growth

5 Americas

5.1 Americas Bicalutamide Sales by Country

5.1.1 Americas Bicalutamide Sales by Country (2017-2022)

5.1.2 Americas Bicalutamide Revenue by Country (2017-2022)

5.2 Americas Bicalutamide Sales by Type

5.3 Americas Bicalutamide Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bicalutamide Sales by Region

6.1.1 APAC Bicalutamide Sales by Region (2017-2022)

6.1.2 APAC Bicalutamide Revenue by Region (2017-2022)

6.2 APAC Bicalutamide Sales by Type

6.3 APAC Bicalutamide Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bicalutamide by Country

7.1.1 Europe Bicalutamide Sales by Country (2017-2022)

7.1.2 Europe Bicalutamide Revenue by Country (2017-2022)

7.2 Europe Bicalutamide Sales by Type

7.3 Europe Bicalutamide Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bicalutamide by Country

8.1.1 Middle East & Africa Bicalutamide Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bicalutamide Revenue by Country (2017-2022)

8.2 Middle East & Africa Bicalutamide Sales by Type

8.3 Middle East & Africa Bicalutamide Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bicalutamide

10.3 Manufacturing Process Analysis of Bicalutamide

10.4 Industry Chain Structure of Bicalutamide

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bicalutamide Distributors

11.3 Bicalutamide Customer

12 World Forecast Review for Bicalutamide by Geographic Region

12.1 Global Bicalutamide Market Size Forecast by Region

12.1.1 Global Bicalutamide Forecast by Region (2023-2028)

12.1.2 Global Bicalutamide Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bicalutamide Forecast by Type

12.7 Global Bicalutamide Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Bicalutamide Product Offered

13.1.3 AstraZeneca Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 CORDEN PHARMA GMBH

13.2.1 CORDEN PHARMA GMBH Company Information

13.2.2 CORDEN PHARMA GMBH Bicalutamide Product Offered

13.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CORDEN PHARMA GMBH Main Business Overview

13.2.5 CORDEN PHARMA GMBH Latest Developments

13.3 Zeneca GmbH

13.3.1 Zeneca GmbH Company Information

13.3.2 Zeneca GmbH Bicalutamide Product Offered

13.3.3 Zeneca GmbH Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zeneca GmbH Main Business Overview

13.3.5 Zeneca GmbH Latest Developments

13.4 Actavis Pharma

13.4.1 Actavis Pharma Company Information

13.4.2 Actavis Pharma Bicalutamide Product Offered

13.4.3 Actavis Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Actavis Pharma Main Business Overview

13.4.5 Actavis Pharma Latest Developments

13.5 Sivem Pharmaceuticals

13.5.1 Sivem Pharmaceuticals Company Information

13.5.2 Sivem Pharmaceuticals Bicalutamide Product Offered

13.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sivem Pharmaceuticals Main Business Overview

13.5.5 Sivem Pharmaceuticals Latest Developments

13.6 Sorres Pharma

13.6.1 Sorres Pharma Company Information

13.6.2 Sorres Pharma Bicalutamide Product Offered

13.6.3 Sorres Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sorres Pharma Main Business Overview

13.6.5 Sorres Pharma Latest Developments

13.7 Fresenius Kabi

13.7.1 Fresenius Kabi Company Information

13.7.2 Fresenius Kabi Bicalutamide Product Offered

13.7.3 Fresenius Kabi Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Fresenius Kabi Main Business Overview

13.7.5 Fresenius Kabi Latest Developments

13.8 ANI Pharmaceuticals

13.8.1 ANI Pharmaceuticals Company Information

13.8.2 ANI Pharmaceuticals Bicalutamide Product Offered

13.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 ANI Pharmaceuticals Main Business Overview

13.8.5 ANI Pharmaceuticals Latest Developments

13.9 Accel Pharma

13.9.1 Accel Pharma Company Information

13.9.2 Accel Pharma Bicalutamide Product Offered

13.9.3 Accel Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Accel Pharma Main Business Overview

13.9.5 Accel Pharma Latest Developments

13.10 Apotex Corporation

13.10.1 Apotex Corporation Company Information

13.10.2 Apotex Corporation Bicalutamide Product Offered

13.10.3 Apotex Corporation Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Apotex Corporation Main Business Overview

13.10.5 Apotex Corporation Latest Developments

13.11 Shanghai Fudan Fuhua Pharmaceutical

13.11.1 Shanghai Fudan Fuhua Pharmaceutical Company Information

13.11.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Offered

13.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shanghai Fudan Fuhua Pharmaceutical Main Business Overview

13.11.5 Shanghai Fudan Fuhua Pharmaceutical Latest Developments

13.12 Shanghai Zhaohui Pharmaceutical

13.12.1 Shanghai Zhaohui Pharmaceutical Company Information

13.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Offered

13.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shanghai Zhaohui Pharmaceutical Main Business Overview

13.12.5 Shanghai Zhaohui Pharmaceutical Latest Developments

13.13 Zhejiang Haizheng Pharmaceutical

13.13.1 Zhejiang Haizheng Pharmaceutical Company Information

13.13.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Offered

13.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Zhejiang Haizheng Pharmaceutical Main Business Overview

13.13.5 Zhejiang Haizheng Pharmaceutical Latest Developments

13.14 Shanxi Zhendong Pharmaceutical

13.14.1 Shanxi Zhendong Pharmaceutical Company Information

13.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Product Offered

13.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shanxi Zhendong Pharmaceutical Main Business Overview

13.14.5 Shanxi Zhendong Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Bicalutamide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bicalutamide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets

Table 4. Major Players of Capsule

Table 5. Global Bicalutamide Sales by Type (2017-2022) & (M Pcs)

Table 6. Global Bicalutamide Sales Market Share by Type (2017-2022)

Table 7. Global Bicalutamide Revenue by Type (2017-2022) & ($ million)

Table 8. Global Bicalutamide Revenue Market Share by Type (2017-2022)

Table 9. Global Bicalutamide Sale Price by Type (2017-2022) & (US$/Pcs)

Table 10. Global Bicalutamide Sales by Application (2017-2022) & (M Pcs)

Table 11. Global Bicalutamide Sales Market Share by Application (2017-2022)

Table 12. Global Bicalutamide Revenue by Application (2017-2022)

Table 13. Global Bicalutamide Revenue Market Share by Application (2017-2022)

Table 14. Global Bicalutamide Sale Price by Application (2017-2022) & (US$/Pcs)

Table 15. Global Bicalutamide Sales by Company (2020-2022) & (M Pcs)

Table 16. Global Bicalutamide Sales Market Share by Company (2020-2022)

Table 17. Global Bicalutamide Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Bicalutamide Revenue Market Share by Company (2020-2022)

Table 19. Global Bicalutamide Sale Price by Company (2020-2022) & (US$/Pcs)

Table 20. Key Manufacturers Bicalutamide Producing Area Distribution and Sales Area

Table 21. Players Bicalutamide Products Offered

Table 22. Bicalutamide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Bicalutamide Sales by Geographic Region (2017-2022) & (M Pcs)

Table 26. Global Bicalutamide Sales Market Share Geographic Region (2017-2022)

Table 27. Global Bicalutamide Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Bicalutamide Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Bicalutamide Sales by Country/Region (2017-2022) & (M Pcs)

Table 30. Global Bicalutamide Sales Market Share by Country/Region (2017-2022)

Table 31. Global Bicalutamide Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Bicalutamide Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Bicalutamide Sales by Country (2017-2022) & (M Pcs)

Table 34. Americas Bicalutamide Sales Market Share by Country (2017-2022)

Table 35. Americas Bicalutamide Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Bicalutamide Revenue Market Share by Country (2017-2022)

Table 37. Americas Bicalutamide Sales by Type (2017-2022) & (M Pcs)

Table 38. Americas Bicalutamide Sales Market Share by Type (2017-2022)

Table 39. Americas Bicalutamide Sales by Application (2017-2022) & (M Pcs)

Table 40. Americas Bicalutamide Sales Market Share by Application (2017-2022)

Table 41. APAC Bicalutamide Sales by Region (2017-2022) & (M Pcs)

Table 42. APAC Bicalutamide Sales Market Share by Region (2017-2022)

Table 43. APAC Bicalutamide Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Bicalutamide Revenue Market Share by Region (2017-2022)

Table 45. APAC Bicalutamide Sales by Type (2017-2022) & (M Pcs)

Table 46. APAC Bicalutamide Sales Market Share by Type (2017-2022)

Table 47. APAC Bicalutamide Sales by Application (2017-2022) & (M Pcs)

Table 48. APAC Bicalutamide Sales Market Share by Application (2017-2022)

Table 49. Europe Bicalutamide Sales by Country (2017-2022) & (M Pcs)

Table 50. Europe Bicalutamide Sales Market Share by Country (2017-2022)

Table 51. Europe Bicalutamide Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Bicalutamide Revenue Market Share by Country (2017-2022)

Table 53. Europe Bicalutamide Sales by Type (2017-2022) & (M Pcs)

Table 54. Europe Bicalutamide Sales Market Share by Type (2017-2022)

Table 55. Europe Bicalutamide Sales by Application (2017-2022) & (M Pcs)

Table 56. Europe Bicalutamide Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Bicalutamide Sales by Country (2017-2022) & (M Pcs)

Table 58. Middle East & Africa Bicalutamide Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Bicalutamide Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Bicalutamide Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Bicalutamide Sales by Type (2017-2022) & (M Pcs)

Table 62. Middle East & Africa Bicalutamide Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Bicalutamide Sales by Application (2017-2022) & (M Pcs)

Table 64. Middle East & Africa Bicalutamide Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Bicalutamide

Table 66. Key Market Challenges & Risks of Bicalutamide

Table 67. Key Industry Trends of Bicalutamide

Table 68. Bicalutamide Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Bicalutamide Distributors List

Table 71. Bicalutamide Customer List

Table 72. Global Bicalutamide Sales Forecast by Region (2023-2028) & (M Pcs)

Table 73. Global Bicalutamide Sales Market Forecast by Region

Table 74. Global Bicalutamide Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Bicalutamide Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Bicalutamide Sales Forecast by Country (2023-2028) & (M Pcs)

Table 77. Americas Bicalutamide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Bicalutamide Sales Forecast by Region (2023-2028) & (M Pcs)

Table 79. APAC Bicalutamide Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Bicalutamide Sales Forecast by Country (2023-2028) & (M Pcs)

Table 81. Europe Bicalutamide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Bicalutamide Sales Forecast by Country (2023-2028) & (M Pcs)

Table 83. Middle East & Africa Bicalutamide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Bicalutamide Sales Forecast by Type (2023-2028) & (M Pcs)

Table 85. Global Bicalutamide Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Bicalutamide Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Bicalutamide Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Bicalutamide Sales Forecast by Application (2023-2028) & (M Pcs)

Table 89. Global Bicalutamide Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Bicalutamide Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Bicalutamide Revenue Market Share Forecast by Application (2023-2028)

Table 92. AstraZeneca Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 93. AstraZeneca Bicalutamide Product Offered

Table 94. AstraZeneca Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 95. AstraZeneca Main Business

Table 96. AstraZeneca Latest Developments

Table 97. CORDEN PHARMA GMBH Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 98. CORDEN PHARMA GMBH Bicalutamide Product Offered

Table 99. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 100. CORDEN PHARMA GMBH Main Business

Table 101. CORDEN PHARMA GMBH Latest Developments

Table 102. Zeneca GmbH Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 103. Zeneca GmbH Bicalutamide Product Offered

Table 104. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 105. Zeneca GmbH Main Business

Table 106. Zeneca GmbH Latest Developments

Table 107. Actavis Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 108. Actavis Pharma Bicalutamide Product Offered

Table 109. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 110. Actavis Pharma Main Business

Table 111. Actavis Pharma Latest Developments

Table 112. Sivem Pharmaceuticals Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 113. Sivem Pharmaceuticals Bicalutamide Product Offered

Table 114. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 115. Sivem Pharmaceuticals Main Business

Table 116. Sivem Pharmaceuticals Latest Developments

Table 117. Sorres Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 118. Sorres Pharma Bicalutamide Product Offered

Table 119. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 120. Sorres Pharma Main Business

Table 121. Sorres Pharma Latest Developments

Table 122. Fresenius Kabi Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 123. Fresenius Kabi Bicalutamide Product Offered

Table 124. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 125. Fresenius Kabi Main Business

Table 126. Fresenius Kabi Latest Developments

Table 127. ANI Pharmaceuticals Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 128. ANI Pharmaceuticals Bicalutamide Product Offered

Table 129. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 130. ANI Pharmaceuticals Main Business

Table 131. ANI Pharmaceuticals Latest Developments

Table 132. Accel Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 133. Accel Pharma Bicalutamide Product Offered

Table 134. Accel Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 135. Accel Pharma Main Business

Table 136. Accel Pharma Latest Developments

Table 137. Apotex Corporation Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 138. Apotex Corporation Bicalutamide Product Offered

Table 139. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 140. Apotex Corporation Main Business

Table 141. Apotex Corporation Latest Developments

Table 142. Shanghai Fudan Fuhua Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 143. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Offered

Table 144. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 145. Shanghai Fudan Fuhua Pharmaceutical Main Business

Table 146. Shanghai Fudan Fuhua Pharmaceutical Latest Developments

Table 147. Shanghai Zhaohui Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 148. Shanghai Zhaohui Pharmaceutical Bicalutamide Product Offered

Table 149. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 150. Shanghai Zhaohui Pharmaceutical Main Business

Table 151. Shanghai Zhaohui Pharmaceutical Latest Developments

Table 152. Zhejiang Haizheng Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 153. Zhejiang Haizheng Pharmaceutical Bicalutamide Product Offered

Table 154. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 155. Zhejiang Haizheng Pharmaceutical Main Business

Table 156. Zhejiang Haizheng Pharmaceutical Latest Developments

Table 157. Shanxi Zhendong Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors

Table 158. Shanxi Zhendong Pharmaceutical Bicalutamide Product Offered

Table 159. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 160. Shanxi Zhendong Pharmaceutical Main Business

Table 161. Shanxi Zhendong Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Bicalutamide

Figure 2. Bicalutamide Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bicalutamide Sales Growth Rate 2017-2028 (M Pcs)

Figure 7. Global Bicalutamide Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bicalutamide Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets

Figure 10. Product Picture of Capsule

Figure 11. Global Bicalutamide Sales Market Share by Type in 2021

Figure 12. Global Bicalutamide Revenue Market Share by Type (2017-2022)

Figure 13. Bicalutamide Consumed in Single Drug For Prostate Cancer

Figure 14. Global Bicalutamide Market: Single Drug For Prostate Cancer (2017-2022) & (M Pcs)

Figure 15. Bicalutamide Consumed in Combined Chemotherapy For Prostate Cancer

Figure 16. Global Bicalutamide Market: Combined Chemotherapy For Prostate Cancer (2017-2022) & (M Pcs)

Figure 17. Bicalutamide Consumed in Combined Radiation Therapy Or Castration For Prostate Cancer

Figure 18. Global Bicalutamide Market: Combined Radiation Therapy Or Castration For Prostate Cancer (2017-2022) & (M Pcs)

Figure 19. Global Bicalutamide Sales Market Share by Application (2017-2022)

Figure 20. Global Bicalutamide Revenue Market Share by Application in 2021

Figure 21. Bicalutamide Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Bicalutamide Revenue Market Share by Company in 2021

Figure 23. Global Bicalutamide Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Bicalutamide Revenue Market Share by Geographic Region in 2021

Figure 25. Global Bicalutamide Sales Market Share by Region (2017-2022)

Figure 26. Global Bicalutamide Revenue Market Share by Country/Region in 2021

Figure 27. Americas Bicalutamide Sales 2017-2022 (M Pcs)

Figure 28. Americas Bicalutamide Revenue 2017-2022 ($ Millions)

Figure 29. APAC Bicalutamide Sales 2017-2022 (M Pcs)

Figure 30. APAC Bicalutamide Revenue 2017-2022 ($ Millions)

Figure 31. Europe Bicalutamide Sales 2017-2022 (M Pcs)

Figure 32. Europe Bicalutamide Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Bicalutamide Sales 2017-2022 (M Pcs)

Figure 34. Middle East & Africa Bicalutamide Revenue 2017-2022 ($ Millions)

Figure 35. Americas Bicalutamide Sales Market Share by Country in 2021

Figure 36. Americas Bicalutamide Revenue Market Share by Country in 2021

Figure 37. United States Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Bicalutamide Sales Market Share by Region in 2021

Figure 42. APAC Bicalutamide Revenue Market Share by Regions in 2021

Figure 43. China Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Bicalutamide Sales Market Share by Country in 2021

Figure 50. Europe Bicalutamide Revenue Market Share by Country in 2021

Figure 51. Germany Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Bicalutamide Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Bicalutamide Revenue Market Share by Country in 2021

Figure 58. Egypt Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Bicalutamide Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Bicalutamide in 2021

Figure 64. Manufacturing Process Analysis of Bicalutamide

Figure 65. Industry Chain Structure of Bicalutamide

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390